Search Results - "Benasso, M."

Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study by Licitra, L., Mesia, R., Rivera, F., Remenár, É., Hitt, R., Erfán, J., Rottey, S., Kawecki, A., Zabolotnyy, D., Benasso, M., Störkel, S., Senger, S., Stroh, C., Vermorken, J.B.

“…The phase III EXTREME study demonstrated that combining cetuximab with platinum/5-fluorouracil (5-FU) significantly improved overall survival in the first-line…”
Get full text

Quality of life of patients receiving platinum-based chemotherapy plus cetuximab first line for recurrent and/or metastatic squamous cell carcinoma of the head and neck by Mesía, R., Rivera, F., Kawecki, A., Rottey, S., Hitt, R., Kienzer, H., Cupissol, D., De Raucourt, D., Benasso, M., Koralewski, P., Delord, J.-P., Bokemeyer, C., Curran, D., Gross, A., Vermorken, J.B.

“…Background: A phase III trial demonstrated that cetuximab is the first agent in 30 years to improve survival when added to platinum-based chemotherapy…”
Get full text

Cisplatin-based chemoradiation plus cetuximab in locally advanced head and neck cancer: a phase II clinical study by Merlano, M., Russi, E., Benasso, M., Corvò, R., Colantonio, I., Vigna-Taglianti, R., Vigo, V., Bacigalupo, A., Numico, G., Crosetto, N., Gasco, M., Lo Nigro, C., Vitiello, R., Violante, S., Garrone, O.

“…Intensification of chemoradiation for advanced head and neck squamous cell carcinoma (HNSCC) is unlikely due to toxicity. Cetuximab combined either with…”
Get full text

Dose-dense adjuvant chemotherapy in early breast cancer: 15–year results of the phase III Mammella InterGruppo (MIG)-1 study by Blondeaux, E., Cantore, M., Michelotti, A., Conte, B., Benasso, M., Bighin, C., Lambertini, M., Poggio, F., Del Mastro, L.

Get full text

Difficulties in conducting pure academic research, obstacles in data collection and quality of informations: The example of the INTERCEPTOR study by Merlano, M, Denaro, N, Benasso, M, Licitra, L, Bossi, P, Locati, L, Vecchio, S, Bruzzi, P

“…Highlights•Interceptor trial compared concurrent chemoradiotherapy with induction chemotherapy followed by Cetuximab RT. We reported difficulty in data…”
Get full text

OC-019: The phase III study INTERCEPTOR: preliminary results by Denaro, N, Vecchio, S, Bagicalupo, A, Russi, E, Rampino, M, Benasso, M, Numico, G, Licitra, L, Ostellino, O, D'amico, M, Curcio, P, Merlano, M

Get full text

2822 Gemcitabine-based chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck: A literature review and meta-analysis by Szturz, P, Vanderveken, O.M, Specenier, P, Merlano, M.C, Benasso, M, Van Gestel, D, Wouters, K, Van Laer, C, Weyngaert, D. Van Den, Peeters, M, Vermorken, J.B

Get full text

2821 The phase III study INTERCEPTOR in locally advanced head and neck cancer (LA-HNC). Preliminary safety report by Merlano, M, Vecchio, S, Bacigalupo, A, Denaro, N, Russi, E, Benasso, M, Vigo, V, Ostellino, O, Rampino, M, Canobbio, L, Grimaldi, A, Blengio, F, Berretta, L, Bui, S, D'Abbiero, N, D'Amico, M, Numico, G, Bergamini, C, Orlandi, E, Aieta, M

Get full text

Complex hepatobiliary surgery in a setting of two major communities hospitals: Comparative analysis with a tertiary community center by Percivale, A, Griseri, G, Benatti, E, Ceriotti, M, Gastaldo, A, Benasso, M, Riccardo, P

Get full text

816 poster ALTERNATING CHEMO-RADIOTHERAPY FOR ADVANCED HEAD AND NECK CANCER: 30 YEARS OF EXPERIENCE IN GENOA by Marcenaro, M, Corvò, R, Bacigalupo, A, Sanguineti, G, Benasso, M, Russi, E.G, Vecchio, S, Merlano, M

Get full text

Radiofrequency-assisted liver resection: Analysis of the operative strategy for oncological liver resection by Percivale, A., MD, Griseri, G., MD, Benatti, E., MD, Gastaldo, A., MD, Benasso, M., MD, Giovanni, S., MD, Pellicci, R., MD

Get full text

Five-Year Update of a Randomized Trial of Alternating Radiotherapy and Chemotherapy Compared With Radiotherapy Alone in Treatment of Unresectable Squamous Cell Carcinoma of the Head and Neck by Merlano, Marco, Benasso, Marco, Corvò, Renzo, Rosso, Riccardo, Vitale, Vito, Blengio, Fulvia, Numico, Gianmauro, Margarino, Giovanni, Bonelli, Luigina, Santi, Leonardo

“…Background: In 1992, we reported the first analysis of a randomized trial comparing alternating radiotherapy and chemotherapy with radiotherapy alone in the…”
Get full text

Impact of the treating institution on the survival of patients with head and neck cancer treated with concomitant alternating chemotherapy and radiation by Benasso, M., Lionetto, R., Corvò, R., Ponzanelli, A., Vitale, V., Rosso, R.

“…The aim of this study was to investigate the possible impact of the treating institution on the survival of patients with advanced squamous cell carcinoma of…”
Get full text

Alternating gemcitabine and cisplatin with gemcitabine and radiation in stage IV squamous cell carcinoma of the head and neck by Benasso, M., Corvò, R., Ponzanelli, A., Sanguineti, G., Ricci, I., Pallestrini, E., Santelli, A., Vitale, V., Rosso, R.

“…Background: In order to improve our cisplatin–5-fluorouracil (5-FU)-based alternating chemo-radiotherapy regimen, in 1996 we started an investigational program…”
Get full text

86ODose-dense adjuvant chemotherapy in early breast cancer: 15–year results of the phase III Mammella InterGruppo (MIG)-1 study by Blondeaux, E, Cantore, M, Michelotti, A, Conte, B, Benasso, M, Bighin, C, Lambertini, M, Poggio, F, Del Mastro, L

Get full text

Induction chemotherapy followed by alternating chemo-radiotherapy in stage IV undifferentiated nasopharyngeal carcinoma by BENASSO, M, SANGUINETI, G, ROSSO, R, D'AMICO, M, CORVO, R, RICCI, I, NUMICO, G, GUARNERI, D, VITALE, V, PALLESTRINI, E, SANTELLI, A

“…In locally advanced undifferentiated nasopharyngeal carcinoma (UNPC), concomitant chemo-radiotherapy is the only strategy that gave better results over…”
Get full text

Treatment with cisplatin and fluorouracil alternating with radiation favourably affects prognosis of inoperable squamous cell carcinoma of the head and neck: Results of a multivariate analysis on 273 patients by Benasso, M., Bonelli, L., Numico, G., Corvò, R., Sanguineti, G., Rosso, R., Vitale, V., Merlano, M.

“…Purpose The goal of the present analyses is to assess the association between different therapeutic approaches and both the probability of achieving a complete…”
Get full text

5501 ORAL Cetuximab plus platinum-based therapy first-line in recurrent and/or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): Efficacy and safety results of a randomized phase III trial (EXTREME) by Vermorken, J.B, Hitt, R, Geoffrois, L, Erfan, J, Kawecki, A, Zabolotnyy, D, Schueler, A, Knecht, R, Benasso, M, Kienzer, H

Get full text

Chemo-Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck: Factors Affecting Toxicity Patterns by Rosso, M., Benasso, M., Rosso, R.

“…Radiation and chemotherapy in the treatment of locally advanced squamous carcinoma of the head and neck can be used according to different strategies:…”
Get full text

Chemotherapy for relapsed head and neck cancer: paclitaxel, cisplatin, and 5-fluorouracil in chemotherapy-naive patients. A dose-finding study by Benasso, M, Numico, G, Rosso, R, Merlano, M, Ricci, I, Gentile, A

“…The aim of this trial was to identify the maximum tolerated dose of paclitaxel (Taxol; Bristol-Myers Squibb Company, Princeton, NJ) administered via a 3-hour…”
Get more information